Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy.
Lejeune P, Cruciani V, Berg-Larsen A, Schlicker A, Mobergslien A, Bartnitzky L, Berndt S, Zitzmann-Kolbe S, Kamfenkel C, Stargard S, Hammer S, Jørgensen JS, Jackerott M, Nielsen CH, Schatz CA, Hennekes H, Karlsson J, Cuthbertson AS, Mumberg D, Hagemann UB.
Lejeune P, et al. Among authors: nielsen ch.
J Immunother Cancer. 2021 Oct;9(10):e002387. doi: 10.1136/jitc-2021-002387.
J Immunother Cancer. 2021.
PMID: 34615703
Free PMC article.